{"organizations": [], "uuid": "e04cc6499ae137511a4d6adaf1ca28b920e7d179", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-orexigen-therapeutics-says-expect/brief-orexigen-therapeutics-says-expect-annualized-savings-associated-with-feb-2018-reduction-in-sales-force-of-about-30-mln-idUSFWN1PE13M", "country": "US", "domain_rank": 408, "title": "BRIEF-Orexigen Therapeutics Says ‍Expect Annualized Savings Associated With Feb 2018 Reduction In Sales Force Of About $30 Mln​", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-19T16:33:00.000+02:00", "replies_count": 0, "uuid": "e04cc6499ae137511a4d6adaf1ca28b920e7d179"}, "author": "", "url": "https://www.reuters.com/article/brief-orexigen-therapeutics-says-expect/brief-orexigen-therapeutics-says-expect-annualized-savings-associated-with-feb-2018-reduction-in-sales-force-of-about-30-mln-idUSFWN1PE13M", "ord_in_thread": 0, "title": "BRIEF-Orexigen Therapeutics Says ‍Expect Annualized Savings Associated With Feb 2018 Reduction In Sales Force Of About $30 Mln​", "locations": [], "entities": {"persons": [{"name": "ann", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "sec", "sentiment": "none"}, {"name": "mln​ reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "orexigen therapeutics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 19 (Reuters) - Orexigen Therapeutics Inc:\n* OREXIGEN THERAPEUTICS SAYS ‍EXPECT ANNUALIZED SAVINGS ASSOCIATED WITH FEB 2018 REDUCTION IN SALES FORCE OF ABOUT $30 MILLION​ - SEC FILING Source text: ( bit.ly/2Bg6XUc ) Further company coverage:\n ", "external_links": [], "published": "2018-01-19T16:33:00.000+02:00", "crawled": "2018-01-19T16:54:00.017+02:00", "highlightTitle": ""}